TriSalus Life Sciences, Inc. Logo

TriSalus Life Sciences, Inc.

Oncology company integrating drug delivery with immunotherapy to treat solid tumors.

TLSI | US

Overview

Corporate Details

ISIN(s):
US58507N2045 (+2 more)
LEI:
Country:
United States of America
Address:
6272 WEST 91ST AVENUE, 80031 WESTMINSTER

Description

TriSalus Life Sciences is an oncology company focused on developing treatments for solid tumors, particularly in the liver and pancreas. The company's therapeutic platform integrates its proprietary Pressure-Enabled Drug Delivery™ (PEDD™) technology with investigational immunotherapies. This integrated approach is designed to overcome critical barriers to treatment, such as high intratumoral pressure and the immunosuppressive tumor microenvironment, which can limit the efficacy of cancer therapies. Key components of its platform include the TriNav® Infusion System for targeted drug delivery and the investigational immunotherapy candidate, nelitolimod. The company aims to improve patient outcomes by enhancing the delivery and effectiveness of treatments, often in combination with systemic immunotherapies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all TriSalus Life Sciences, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for TriSalus Life Sciences, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for TriSalus Life Sciences, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.